iRhythm Technologies Inc Corporate Call to Coincide with the 2020 AHA Scientific Sessions Transcript
Ladies and gentlemen, thank you for standing by, and welcome to the iRhythm mSToPS Update Call. (Operator Instructions) Please be advised that today's conference is being recorded. (Operator Instructions) I would now like to hand the conference over to your speaker today, Kevin King, CEO. Thank you. Please go ahead, sir.
Thank you, operator. Hi, everyone. Thanks for joining our call this afternoon.
Before we get started, I want to remind everyone that we'll be making forward-looking statements during today's presentation, and we encourage you to review the risk factors included in our most recent filings with the SEC.
As you already know, iRhythm participates in a large and growing market for the diagnosis of cardiac arrhythmias for symptomatic patients. And that we're making great progress and substantial inroads into becoming the leader -- leading provider of services with our highly differentiated Zio platform.
Today, I'm pleased that Dr. Steve Steinhubl is
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |